Clinical and Economic Impact of an Electronic Medical Record Interfaced Decision Support System for Minimizing Severe Drug-Drug Interactions

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01765595

Acronym

DDI+

Enrollment

715

Registered

2013-01-10

Start date

2013-01-31

Completion date

2014-10-31

Last updated

2014-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthcare

Keywords

health care expenditure, drug drug interactions, electronic decision support systems, Potential reduction

Brief summary

Leumit Health Services, an health maintenance organization operating in Israel, will incorporate a web-based, decision support system for handling drug-drug interactions and drug information, termed DDI+. the investigators hypothesize that implementing such a system will reduce health-care expenditures (e.g., hospital admissions, referrals to ERs, Imaging procedures).

Interventions

OTHERDDI+

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Number of chronic concomitant drugs ≥5

Exclusion criteria

* Patients diagnosed with HIV/AIDS, and/or viral hepatitis B or C.

Design outcomes

Primary

Measure	Time frame
Hospital Admissions	up to 12 months post initiation

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026